Observational studyPloS one2022

Efficacy and safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive and biological therapy: Prospective observational study.

Martin Wasserbauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.